THE HATCH-WAXMAN ACT: A PATH FORWARD FOR MAKING IT MORE MODERN.

The article discusses several aspects of the U.S. Drug Price Competition and Patent Term Restoration (Hatch-Waxman) Act of 1984, and it mentions consumer legislation in America, a legal and economic framework for the nation's generic drug industry, and pathways for drug approval in the U.S. Drug patent protection and America's legislative history are examined, along with the U.S. Biologics Price Competition and Innovation Act of 2009 (Biosimilars Act) and the marketing of medicines.